SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,867.48 179.64
(0.35%)

Dow Jones

7,378.60 -7.86
(-0.11%)

Hang Seng

72,467.78 3,292.81
(4.76%)

Nikkei 225

10,453.87 25.02
(0.24%)

Forex

USD-INR

94.74 0.21
(0.22%)

EUR-INR

108.00 -0.19
(-0.17%)

GBP-INR

125.20 0.11
(0.09%)

JPY-INR

0.59 0.00
(0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.8745685

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

68.61

380.08

EPS(TTM)

Face Value()

Div & Yield %

1.02

Back

Gamco reports consolidated net loss of Rs 4.76 crore in the December 2025 quarter

Jan 24,2026

Net Loss of Gamco reported to Rs 4.76 crore in the quarter ended December 2025 as against net loss of Rs 4.94 crore during the previous quarter ended December 2024. Sales rose 1486.74% to Rs 86.16 crore in the quarter ended December 2025 as against Rs 5.43 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	86.16	5.43	1487
OPM %	-1.13	-79.01	-
PBDT	-5.66	-5.82	3
PBT	-5.86	-5.94	1
NP	-4.76	-4.94	4

77,100.47 109.25 ( 0.14%)

51,867.48 179.64 (0.35%)

7,378.60 -7.86 (-0.11%)

72,467.78 3,292.81 (4.76%)

10,453.87 25.02 (0.24%)

94.74 0.21 (0.22%)

108.00 -0.19 (-0.17%)

125.20 0.11 (0.09%)

0.59 0.00 (0.26%)